FDA Investigator Allen Lou

Allen Lou has conducted inspections on 68 sites in 1 countries as of 16 Jun 2008. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
68
Last Inspection Date:
16 Jun 2008
Investigator Role:
FDA Investigator
Redica ID:
100001412
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Allen Lou:
Alberto A Viciedo, Amy L Singer, Amy M Cramer, Ana S Cabrera, Ann Marie Montemurro, Annemarie Bodnar, Anthony M Criscuolo, Jr, Barbara J Maulfair, Barbara L Rellahan, PhD, Brian S Keefer, Byungja E Marciante, Cara M Minelli, Cary Greene, Charles J Chacko, Cheryl A Grandinetti, Cheryl J Legrand, Christina N Maurino, Craig W Swanson, Daniel J Grabicki, Dawn L Wydner, Deborah B Nixon, Denise M Visco, Investigator, Dhaval H Patel, Diane B Radice, Doreen P Gubbay, Dorothy J Denes, Douglas C Kovacs, Dr. Gopa Biswas, PhD, Dr. Zhou Chen (nmi), MD PhD, Edward D Mcdonald, Emest F Bizjak, Emmanuel Jramos Maldonado, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Frank J Marciniak, George Pyramides, Gianine E Delade, Gianine E Tompkins, Guerlain Ulysse, Helen B Ricalde, Helen Verdel, Hitesh R Patel, Jacob M Dyer, Jacqueline Mdiaz Albertini, Jason Kwong, Jean M Kelahan, Jeffrey J Ebersole, Jessica S Estriplet, Joan A Loreng, Jogy George, Jonee J Mearns, Jose M Cayuela, Joseph F Mcginnis, RPh, Josh Renzo N Ramilo, Joy Rkozlowski Klena, Juanita P Versace, Justin H Price, Karen E D'orazio, Karen F Tomaziefski, Kassa Ayalew, MD, Keith M Reilly, Kelli F Dobilas, Kelly Doremus, Kerry A Kurdilla, Kinh Q Mac, Kristy A Zielny, Krystal O Ogunremi, Laishan L Lam, Lata C Mathew, PhD, Lawrence R Johnson, Li Li, Liatte Kreuger, PharmD, Lisa Harlan, Lisa Mathew, Loretta Nemchik, LT Colin E Tack, BSE, Luella J Rossi, Marcelo O Mangalindan, Jr, Marcia D Fields, Margaret M Sands, Marjorie D Schultz, Matthew A Spataro, Mayar M Mussa, Melba Trivera Clavell, Melissa A Freeman, Melissa A Zuppe, Melissa B Libby, Melissa T Roy, Meredith L Sheridan, Michael F Skelly, PhD, Michael J Nerz, Michael R Klapal, Michael Serrano, Miguel Gmanzano Maldonado, Nancy F Scheraga, Nancy L Rolli, Nilufer M Tampal, PhD, Nina Yang, Niraj R Mehta, PhD, Omotunde O Osunsanmi, Paul L Bellamy, Paula A Trost, Peter R Lenahan, Prabhu P Raju, Rabin N Ghoshal, Raffi B Papazian, Raymond L Cheung, Regina T Brown, Richard D Manney, Robert G Ruff, Robert Jennings, Rodney T Allnutt, Rose Ashley, Saleem A Akhtar, Sandra Kershaw, Sarah Adella Fave, Sarah Forney, Schultz, Sherri J Liu, Shirley H Isbill, Shirley S Wen, Sidney B Priesmeyer, Sinai I Davis, Stephanie T Durso, Stephen J Mottola, Susan M Halsted, Tania E Vizcaino, Tara G Bizjak, Tara K Carmody, Tara R Gooen, Thomas J Arista, Tonia F Bernard, Tressa T Lewis, Tyanna N Hadley, Valerie C Reed, Valerie Reed, Wayne J Meyer, William J Leonard, William R Chang, Willy A Orantes, Xikui Chen (nmi), PhD, Yvesna C Blaise

Allen Lou's Documents

Publish Date Document Type Title
August, 2006 FDA 483 Novartis Pharmaceuticals Corporation - Form 483, 2006-08-29
April, 2003 EIR Datascope Corp. - EIR, 2003-04-16
October, 2007 FDA 483 Merck Sharp & Dohme - Form 483, 2007-10-05
December, 2006 FDA 483 Schering Corporation - Form 483, 2006-12-20
May, 2005 FDA 483 ReGen Biologics, Inc. - Form 483, 2005-05-18
February, 2006 FDA 483 Caraustar Custom Packaging Group - Form 483, 2006-02-10
October, 2003 FDA 483 Response Hackensack Meridian Health IRB - Form 483R, 2003-11-04
November, 2002 FDA 483 Vygon U.S.A. - Form 483, 2002-11-25
May, 2006 FDA 483 Novartis Pharmaceuticals Corporation - Form 483, 2006-05-01
October, 2003 FDA 483 Hackensack Meridian Health IRB - Form 483, 2003-10-30
June, 2006 FDA 483 Merck & Co., Inc. - Form 483, 2006-06-23
February, 2007 FDA 483 Inopak Ltd - Form 483, 2007-02-05
October, 2003 EIR Hackensack Meridian Health IRB - EIR, 2003-10-30
March, 2007 FDA 483 Scott D. Rowley, M.D. - Form 483, 2007-03-28
April, 2003 EIR Vygon U.S.A. - EIR, 2003-04-23
September, 2005 FDA 483 Merck & Co., Inc. - Form 483, 2005-09-16
May, 2005 EIR ReGen Biologics, Inc. - EIR, 2005-05-18
March, 2007 EIR Scott D. Rowley, M.D. - EIR, 2007-03-28
August, 2003 EIR Roche Molecular Systems, Inc. - EIR, 2003-08-06
August, 2006 EIR Novartis Pharmaceuticals Corporation - EIR, 2006-08-29
May, 2006 EIR Novartis Pharmaceuticals Corporation - EIR, 2006-05-01
September, 2005 FDA 483 Response McNeil PPC Inc. - Form 483R, 2005-10-20
April, 2005 EIR Hoffmann La Roche Inc - EIR, 2005-04-04
September, 2005 FDA 483 McNeil PPC Inc. - Form 483, 2005-09-29
November, 2005 EIR McNeil PPC Inc. - EIR, 2005-11-07
September, 2005 EIR McNeil PPC Inc. - EIR, 2005-09-29
April, 2005 FDA 483 Hoffmann La Roche Inc - Form 483, 2005-04-04

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more